US Exempts Indian Pharmaceuticals From Tariff Hike Amid Dependence On Generics
The Indian pharmaceutical industry has been exempted from the US tariff hike, announced by President Trump on 27 August, after raising India-related tariffs to 50% on Russian oil purchases.
Indian Pharma Industry Sees Robust Sustainable Growth And Innovation In 2024
The Indian pharma industry has established itself as a key driver of knowledge for the nation's economy while being the manufacturing hub.
